Cargando…
Immune reconstitution of HLA-A*0201/BMLF1- and HLA-A*1101/LMP2-specific Epstein Barr virus cytotoxic T lymphocytes within 90 days after haploidentical hematopoietic stem cell transplantation
BACKGROUND: Haploidentical hematopoietic stem cell transplant (haplo-HSCT) recipients are at high risk for Epstein Barr virus (EBV)-related diseases. EBV-specific CD8(+) cytotoxic T cells can control EBV-infected B cell expansion; however, no studies have investigated EBV-specific immune reconstitut...
Autores principales: | Zhou, Ling, Lu, Dao-pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6368816/ https://www.ncbi.nlm.nih.gov/pubmed/30736814 http://dx.doi.org/10.1186/s12985-019-1123-y |
Ejemplares similares
-
Editorial: The Immunobiology of HLA-Haploidentical Hematopoietic Cell Transplantation
por: Mancusi, Antonella, et al.
Publicado: (2020) -
Identification of new HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from neuritin
por: Yang, Zhao, et al.
Publicado: (2013) -
Cross-reactivity of self-HLA-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes for allo-HLA determinants
Publicado: (1983) -
The Epstein-Barr Virus Lytic Protein BMLF1 Induces Upregulation of GRP78 Expression through ATF6 Activation
por: Chen, Lee-Wen, et al.
Publicado: (2021) -
Prediction and identification of novel HLA-A*0201-restricted cytotoxic T lymphocyte epitopes from endocan
por: Shao, Gaohai, et al.
Publicado: (2020)